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Introduction
✲Woburn & North Andover Pediatric Associates
• Woburn Pediatric Associates (WPA) is a primary care pediatric office that 
was founded by Dr. Joseph Leader on August 15th, 1967.
• Dr. Leader is still practicing medicine full-time alongside 14 other physicians 
and 8 nurse practitioners.
• WPA is a part of PPOC (Pediatric Physicians Organization at Children’s).
• North Andover Pediatric Associates (NAPA) officially opened in 1998.
• In 2015, Woburn Pediatric Psychological Services (WPPS) opened as a sub 
separate practice, integrated into the Behavioral Health Department, with 
one full-time psychiatric MD, two part-time psychiatric MDs, and one full-
time licensed independent clinical social worker (LICSW).
✲What are SSRIs?
• Selective Serotonin Reuptake Inhibitors (SSRIs) are a class of prescription 
antidepressants. 
• SSRIs initiate the reuptake of serotonin in the brain, allowing for greater 
production of serotonin.
• Prozac (fluoxetine), Zoloft (sertraline), Lexapro (escitalopram), and Celexa 
(citalopram) are the most prescribed SSRI medications.
• SSRIs are the recommended first-line prescription drug for the treatment of 
anxiety and depressive disorders.
• SSRIs are subject to the FDA’s black box warning due to increased risk for 
suicide ideations.
• “In the collaborative care model (CCM), treatment is closely monitored 
through regular measurement and observation by care managers (13). 
There is a substantial evidence base for collaborative care, including 
more than 80 randomized controlled trials, suggesting that collaborative 
care is twice as effective as usual primary care treatment of patients 
with depression.” (Sowa et al., 2018)
• “Studies have shown that up to 9 percent of teenagers meet criteria for 
depression at any one time, with as many as 1 in 5 teens having a history 
of depression at some point during adolescence. Major depressive 
disorder (MDD) in youth is under-identified and undertreated in 
primary care (PC) settings.” (Nakaishi, 2)
• “The most recent and presumably best, analyses suggest that there may 
be a very slight increased risk of suicidality with antidepressants in 
children and adolescents, but not an actual increased risk of completed 
suicide. Since the time of this black box warning, PCPs have prescribed 
less SSRIs, and the rates of suicide in youth have increased.” (Nakaishi, 6)
Related Literature 
• A patient is diagnosed with anxiety or depression and prescribed an SSRI for 
treatment by their pediatrician.
• The Behavioral Health Director is notified of patients prescribed an SSRI.
• Patient identifiers, as well as other relevant information applying to patients, 
are recorded in the SSRI Excel Spreadsheet.
• The Behavioral Health Director calls the patient approximately 7 days after 
starting their medication to ask the patient standard questions regarding side 
effects. The following programs were used to record their responses:
– Epic to:
§ open and close telephone encounters for scheduling follow-up 
appointments
§ create SSRI Care Coordination Notes in patients' chart
§ update SSRI Spreadsheet on Excel 
§ analyze and surveil patient SSRI treatment progress by 
reviewing patient’s PHQ-9 and GAD-7 scores from each follow-up 
visit since starting medication
– Excel to:
§ investigate patient records on Epic when necessary
§ complete each patient’s SSRI Care Coordination Note
Materials & Methods
• Explored and evaluated the efficacy of care coordination models for 
monitoring SSRIs in a pediatric primary care setting.
• Outlined critical information for each patient prescribed an SSRI for the 
treatment of a mental health disorder by creating a Patient Care 
Coordination Note (PCCN) on Epic, an electronic medical record (EMR) 
software.
• Maintained confidentiality of patient medical records, complying with strict 
HIPAA Privacy Regulations and standard operational policies.
• Updated scheduled SSRI follow-up appointments on Excel each week
• Alerted Site Supervisor of any suspected SSRI Protocol errors.
• Collaborated with Behavioral Health team, providers, and nurses to create 
patient care plans.
• Acted in Accordance with Health Information Privacy and HIPAA 
Compliance Laws.
Objectives Results
✲ This graph shows the PHQ-9 Survey scores of randomly selected patients 
undergoing SSRI treatment for three months before the SSRI Protocol had been 
implemented as well as after the SSRI Protocol had been implemented.
Conclusions
• As the graph above shows, since implementing the SSRI Protocol in 
January, there has been a downward trend in patient’s PHQ-9 scores. 
This data confirms that the SSRI protocol is indeed an effective 
collaborative care measure.
o Continuing this study for an additional three-months would 
allow for more definitive results. 
o Limitations to this study include the COVID-19 lockdown 
changes; increasing and decreasing effects of mental health 
disorders; the change in weather; situational depression; as well 
as the short timespan this study was conducted over.
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✲ WPA’s & NAPA’s SSRI Protocol 
✲ The Patient Health Questionnaire-9 (PHQ-9) is a tool for 
screening, diagnosing, monitoring, and assessing the intensity of 
depression.
